Skip to product information
1 of 1

Biotin Mouse Anti-Human CD159a Antibody (S-2919)

Biotin Mouse Anti-Human CD159a Antibody (S-2919)

Catalog Number: S0B80062 Application: FCM Reactivity: Human Conjugation: Biotin Brand: Starter
Price:
Regular price $200 USD
Regular price Sale price $200 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD159a
Synonyms NKG2-A/NKG2-B type II integral membrane protein; CD159 antigen-like family member A; NK cell receptor A; NKG2-A/B-activating NK receptor; NKG2A; KLRC1
Location Cell membrane
Accession P26715
Clone Number S-2919
Antibody Type Mouse mAb
Isotype IgG1,k
Application FCM
Reactivity Hu
Positive Sample Human PBMC
Purification Protein G
Concentration 0.2 mg/ml
Conjugation Biotin
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu

Background

CD159a (also known as NKG2A or KLRC1) is a 40 kDa (under reducing conditions) or 75 kDa (under non-reducing conditions) type II transmembrane protein belonging to the C-type lectin family (Ca²⁺-dependent). It forms a disulfide-linked heterodimer with CD94 (CD94/NKG2A), functioning as an inhibitory receptor on NK cells that recognizes MHC class I molecules (such as HLA-E) with broader specificity compared to KIR (killer cell immunoglobulin-like receptors). The intracellular domain of CD159a contains two ITIM motifs (immunoreceptor tyrosine-based inhibitory motifs), which transmit inhibitory signals to regulate the activity of NK cells and certain subsets of T cells, preventing attacks on healthy tissues.This protein is primarily expressed in NK cells, NKT cells, and activated CD8⁺ T cells. By binding to CD94, it modulates immune responses, playing a critical role in transplantation immunity and tumor immunity. Additionally, dysregulated expression of CD159a is associated with immune tolerance and disease states, making it a potential therapeutic target for immunosuppressive drug development.

Picture

FC

Flow cytometric analysis of human CD159a expression on human PBMC (human peripheral blood mononuclear cell). Human PBMC were stained with Brilliant Violet 421™ Mouse Anti-Human CD3 Antibody and either Biotin Mouse IgG1, κ Isotype Control (left panel) or SDT Biotin Mouse Anti-Human CD159a Antibody (right panel) at 5 μl/test followed by Sav-iFluor 488. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.